Amgen Statistics

Total Valuation

Amgen has a market cap or net worth of EUR 152.70 billion. The enterprise value is 191.50 billion.

Market Cap	152.70B
Enterprise Value	191.50B

Important Dates

The next estimated earnings date is Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Nov 20, 2025

Share Statistics

Current Share Class	538.48M
Shares Outstanding	n/a
Shares Change (YoY)	+0.28%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	0.15%
Owned by Institutions (%)	80.83%
Float	537.12M

Valuation Ratios

The trailing PE ratio is 25.58 and the forward PE ratio is 15.92.

PE Ratio	25.58
Forward PE	15.92
PS Ratio	4.98
PB Ratio	18.63
P/TBV Ratio	n/a
P/FCF Ratio	15.53
P/OCF Ratio	13.65
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.35, with an EV/FCF ratio of 19.47.

EV / Earnings	32.08
EV / Sales	6.19
EV / EBITDA	13.35
EV / EBIT	19.96
EV / FCF	19.47

Financial Position

The company has a current ratio of 1.28, with a Debt / Equity ratio of 5.67.

Current Ratio	1.28
Quick Ratio	0.82
Debt / Equity	5.67
Debt / EBITDA	3.27
Debt / FCF	4.73
Interest Coverage	3.32

Financial Efficiency

Return on equity (ROE) is 81.71% and return on invested capital (ROIC) is 10.56%.

Return on Equity (ROE)	81.71%
Return on Assets (ROA)	7.71%
Return on Invested Capital (ROIC)	10.56%
Return on Capital Employed (ROCE)	16.33%
Revenue Per Employee	1.09M
Profits Per Employee	213,227
Employee Count	28,000
Asset Turnover	0.40
Inventory Turnover	1.57

Taxes

In the past 12 months, Amgen has paid 1.06 billion in taxes.

Income Tax	1.06B
Effective Tax Rate	15.03%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	270.05
200-Day Moving Average	n/a
Relative Strength Index (RSI)	51.42
Average Volume (20 Days)	115

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.07

Income Statement

In the last 12 months, Amgen had revenue of EUR 30.66 billion and earned 5.97 billion in profits. Earnings per share was 11.02.

Revenue	30.66B
Gross Profit	21.48B
Operating Income	9.51B
Pretax Income	7.03B
Net Income	5.97B
EBITDA	14.05B
EBIT	9.51B
Earnings Per Share (EPS)	11.02

Full Income Statement

Balance Sheet

The company has 8.05 billion in cash and 46.52 billion in debt, giving a net cash position of -38.47 billion.

Cash & Cash Equivalents	8.05B
Total Debt	46.52B
Net Cash	-38.47B
Net Cash Per Share	n/a
Equity (Book Value)	8.20B
Book Value Per Share	15.22
Working Capital	5.19B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 11.19 billion and capital expenditures -1.35 billion, giving a free cash flow of 9.83 billion.

Operating Cash Flow	11.19B
Capital Expenditures	-1.35B
Free Cash Flow	9.83B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 70.05%, with operating and profit margins of 31.02% and 19.47%.

Gross Margin	70.05%
Operating Margin	31.02%
Pretax Margin	22.92%
Profit Margin	19.47%
EBITDA Margin	45.82%
EBIT Margin	31.02%
FCF Margin	32.08%

Dividends & Yields

This stock pays an annual dividend of 6.23, which amounts to a dividend yield of 2.12%.

Dividend Per Share	6.23
Dividend Yield	2.12%
Dividend Growth (YoY)	-25.34%
Years of Dividend Growth	4
Payout Ratio	72.03%
Buyback Yield	-0.28%
Shareholder Yield	1.84%
Earnings Yield	3.91%
FCF Yield	6.44%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Amgen has an Altman Z-Score of 1.69 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.69
Piotroski F-Score	7